Hence, the purpose of our study was to investigate the changes in the circulating GDF15 levels in a pediatric cohort of children with a liver biopsy-proven diagnosis of MASLD and to evaluate the possible association of GDF15 with the different metabolic and hepatic features that characterize the disease. Here, GDF15 is linked to metabolic dysfunction-associated steatotic liver disease.